BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$26.80
+$1.06 (+4.12%)
At close: Sep 21, 2026, 4:00 PM ET
$26.14
-$0.66 (-2.46%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q1 2026 Mar 30, 2026 | Q1 2025 Mar 30, 2025 |
|---|---|---|
PE Ratio | -22.22 | -44.44 |
PEG Ratio | n/a | n/a |
PS Ratio | n/a | n/a |
PB Ratio | -3.06 | n/a |
P/FCF Ratio | -22.21 | -40.88 |
P/OCF Ratio | -22.22 | -42.38 |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | -0.15 | n/a |
Quick Ratio | 7.40 | n/a |
Current Ratio | 7.40 | n/a |
Asset Turnover | n/a | n/a |
Interest Coverage | n/a | n/a |
Return on Equity | 13.81% | n/a |
Return on Assets | -14.65% | n/a |
Return on Invested Capital | -17.31% | n/a |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BLSM